{{Rsnum
|rsid=2070947
|Gene=ITGB2
|Chromosome=21
|position=44920928
|Orientation=minus
|GMAF=0.2002
|Gene_s=ITGB2,TMEM26
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 44.2 | 52.2
| HCB | 2.2 | 38.7 | 59.1
| JPT | 8.8 | 36.3 | 54.9
| YRI | 0.0 | 2.0 | 98.0
| ASW | 1.8 | 14.0 | 84.2
| CHB | 2.2 | 38.7 | 59.1
| CHD | 4.6 | 28.4 | 67.0
| GIH | 1.0 | 31.7 | 67.3
| LWK | 0.0 | 0.0 | 0.0
| MEX | 5.2 | 41.4 | 53.4
| MKK | 0.0 | 5.8 | 94.2
| TSI | 7.8 | 48.0 | 44.1
| HapMapRevision=28
}}

{{Venter SNP
|rsid=2070947
|allele=G
|frequency=0.203
|uid=1103643133004
|type=heterozygous_SNP
|hugo=ITGB2
|ensembl gene=ENSG00000160255
|ensembl transcript=ENST00000302347
|sift=
|disease=Defects in ITGB2 are the cause of leukocyte adhesion deficiency type I (LAD1) (MIM:116920). LAD1 patients have recurrent bacterial infections and their leukocytes are deficient in a wide range of adhesion-dependent functions.
}}

{{PMID Auto
|PMID=23388428
|Title=Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}